Eli Lilly plans to spend another $5.3 billion building production capacity for its popular obesity and diabetes drugs, responding to...
Medicine
A top Food and Drug Administration official on Friday again advocated for the speedy approval of gene therapies for rare...
BioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what...
An older form of hormone therapy taken to ease the symptoms of menopause could increase the risk of ovarian cancer,...
Dive Brief: Biogen is scooping up a closely held immunology startup to bring more diversity to a pipeline best known...
Pfizer, already in the midst of an aggressive effort to trim spending, on Wednesday disclosed new plans to cut at...
Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will...
Dive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of roughly one...
British biotechnology startup Pheon Therapeutics has raised another $120 million in venture funding, riding a wave of investor interest in...
Forbion, a well-known backer of life sciences startups, is leading an investment round for a newly launched biotechnology company focused...